141 related articles for article (PubMed ID: 2011609)
1. Substrate inactivation of lung thromboxane synthase preferentially decreases thromboxane A2 production.
Hall ER; Townsend GL; Linthicum DS; Frasier-Scott KF
Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):31-7. PubMed ID: 2011609
[TBL] [Abstract][Full Text] [Related]
2. Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.
Hall ER; Tuan WM; Venton DL
Biochem J; 1986 Feb; 233(3):637-41. PubMed ID: 3707514
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of thromboxane synthase with hydroperoxy-fatty acids.
Hall ER; Townsend G; Frasier-Scott KF
Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):19-22. PubMed ID: 2011608
[TBL] [Abstract][Full Text] [Related]
4. Immobilization of catalytically active thromboxane synthase.
Hall ER; Townsend GL; Tuan WM; Venton DL
Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):51-6. PubMed ID: 3406040
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
Hornberger WB; Patscheke H
Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
Patscheke H; Hornberger W; Zehender H
Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of prostaglandin endoperoxide by microsomes from human lung parenchyma and comparison with metabolites produced by pig, bovine, rat, mouse and guinea-pig.
Ally AI; Boucher R; Knowles MR; Eling TE
Prostaglandins; 1982 Oct; 24(4):575-84. PubMed ID: 6758042
[TBL] [Abstract][Full Text] [Related]
9. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of ibuprofen, indomethacin, and meclofenamate on prostaglandin endoperoxide H2 metabolism.
Mayeux PR; Kadowitz PJ; McNamara DB
Mol Cell Biochem; 1989 May; 87(1):41-6. PubMed ID: 2505061
[TBL] [Abstract][Full Text] [Related]
12. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA
J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042
[TBL] [Abstract][Full Text] [Related]
13. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
McNamara DB; Harrington JK; Bellan JA; Graybar GB; Underwood DC; Kadowitz PJ
Mol Cell Biochem; 1989 Jan; 85(1):29-41. PubMed ID: 2725478
[TBL] [Abstract][Full Text] [Related]
16. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
17. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
Hornberger W; Patscheke H
Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
[TBL] [Abstract][Full Text] [Related]
18. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 biosynthesis inhibitors: synthesis and evaluation of pyrazolotriazinyl alkanoic acids.
Lasserre B; Mavel S; Coudert P; Pham Huu Chanh A; Navarro-Delmasure C; Dossou-Gbete V; Couquelet J
Prostaglandins Leukot Essent Fatty Acids; 1994 Sep; 51(3):157-61. PubMed ID: 7824529
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
